-
2
-
-
0023031031
-
Frequency and prognostic importance of pretreatment and clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy
-
O'Connell J.P., Kris M.G., Gralla R.J. et al. Frequency and prognostic importance of pretreatment and clinical characteristics in patients with advanced non-small cell lung cancer treated with combination chemotherapy. J Clin Oncol. 4:1986;1604-1614.
-
(1986)
J Clin Oncol
, vol.4
, pp. 1604-1614
-
-
O'Connell, J.P.1
Kris, M.G.2
Gralla, R.J.3
-
3
-
-
0026417636
-
Brief intensive chemotherapy for metastatic non-small cell lung cancer: A phase II study of the weekly CODE regimen
-
Murray N., Osoba D., Shah A. et al. Brief intensive chemotherapy for metastatic non-small cell lung cancer: a phase II study of the weekly CODE regimen. J Natl Cancer Inst. 83:1991;190-194.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 190-194
-
-
Murray, N.1
Osoba, D.2
Shah, A.3
-
5
-
-
0001184894
-
A pharmacokinetic hypothesis for the clinical efficacy of etoposide in small cell lung cancer
-
Clark P.I., Joel S.P., Slevin M.L. A pharmacokinetic hypothesis for the clinical efficacy of etoposide in small cell lung cancer. Proc Am Soc Clin Oncol. 8:1989;66.
-
(1989)
Proc Am Soc Clin Oncol
, vol.8
, pp. 66
-
-
Clark, P.I.1
Joel, S.P.2
Slevin, M.L.3
-
6
-
-
0023695848
-
Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide
-
Loehrer P.J., Lauer R., Roth B.J. et al. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med. 109:1988;540-546.
-
(1988)
Ann Intern Med
, vol.109
, pp. 540-546
-
-
Loehrer, P.J.1
Lauer, R.2
Roth, B.J.3
-
7
-
-
0022911064
-
Appetite stimulation with megestrol acetate in cachectic cancer patients
-
Tchekmedyian N.S., Tait N., Moody F. et al. Appetite stimulation with megestrol acetate in cachectic cancer patients. Semin Oncol. 13:1986;37-43.
-
(1986)
Semin Oncol
, vol.13
, pp. 37-43
-
-
Tchekmedyian, N.S.1
Tait, N.2
Moody, F.3
-
8
-
-
0027406112
-
Body composition changes in patients who gain weight while receiving megestrol acetate
-
Loprinzi C.L., Schaid D.J., Dose A.M. et al. Body composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol. 11:1993;152-154.
-
(1993)
J Clin Oncol
, vol.11
, pp. 152-154
-
-
Loprinzi, C.L.1
Schaid, D.J.2
Dose, A.M.3
-
9
-
-
0026740918
-
Granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor
-
Liesschke G.J., Burgess A.W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony stimulating factor. N Engl J Med. 327:1992;28-35.
-
(1992)
N Engl J Med
, vol.327
, pp. 28-35
-
-
Liesschke, G.J.1
Burgess, A.W.2
-
10
-
-
0028302760
-
Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: A phase I study with apparent activity in non-small cell lung cancer
-
Krigel R.L., Palackdharry C.S., Padavic K. et al. Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small cell lung cancer. J Clin Oncol. 12:1994;1251-1258.
-
(1994)
J Clin Oncol
, vol.12
, pp. 1251-1258
-
-
Krigel, R.L.1
Palackdharry, C.S.2
Padavic, K.3
-
11
-
-
0030836373
-
Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer
-
Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol. 15:1997;2996-3018.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2996-3018
-
-
-
12
-
-
0024492873
-
Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC
-
Buccheri G.F., Ferrigno D., Curcio A. et al. Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Cancer. 63:1989;428-432.
-
(1989)
Cancer
, vol.63
, pp. 428-432
-
-
Buccheri, G.F.1
Ferrigno, D.2
Curcio, A.3
-
13
-
-
0005574455
-
Duration of chemotherapy for advanced non-small cell lung cancer (NSCLC): a phase III randomized trial of 3 versus 6 courses of mitomycin c, vinblastine and cisplatin (MVP)
-
Abstract
-
Smith IE, O'Brien MER, Norton A, et al. Duration of chemotherapy for advanced non-small cell lung cancer (NSCLC): a phase III randomized trial of 3 versus 6 courses of mitomycin c, vinblastine and cisplatin (MVP). Proc ASCO 1998, Abstract 1759.
-
(1998)
Proc ASCO
, vol.1759
-
-
Smith, I.E.1
O'Brien, M.E.R.2
Norton, A.3
-
14
-
-
0025800331
-
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer
-
Crawford J., Ozer H., Stoller R. et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med. 325:1991;164-170.
-
(1991)
N Engl J Med
, vol.325
, pp. 164-170
-
-
Crawford, J.1
Ozer, H.2
Stoller, R.3
-
15
-
-
0027390482
-
Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy
-
Trillet-Lenoir V., Green J., Manegold C. et al. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer. 29A:1993;319.
-
(1993)
Eur J Cancer
, vol.29
, pp. 319
-
-
Trillet-Lenoir, V.1
Green, J.2
Manegold, C.3
-
16
-
-
8044245919
-
CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer
-
Fukuoka M., Masuda N., Negoro S. et al. CODE chemotherapy with and without granulocyte colony-stimulating factor in small-cell lung cancer. Br J Cancer. 75:1997;306-309.
-
(1997)
Br J Cancer
, vol.75
, pp. 306-309
-
-
Fukuoka, M.1
Masuda, N.2
Negoro, S.3
-
17
-
-
0028277451
-
Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small cell lung cancer
-
Eguchi K., Kabe J., Kudo S. et al. Efficacy of recombinant human granulocyte-macrophage colony-stimulating factor for chemotherapy-induced leukopenia in patients with non-small cell lung cancer. Cancer Chemother Pharmacol. 34:1994;37-43.
-
(1994)
Cancer Chemother Pharmacol
, vol.34
, pp. 37-43
-
-
Eguchi, K.1
Kabe, J.2
Kudo, S.3
-
18
-
-
0026754371
-
Usefulness of megestrol acetate in cancer cachexia and anorexia
-
Feliu J., Gonzalez-Bron M., Berocal A. et al. Usefulness of megestrol acetate in cancer cachexia and anorexia. Am J Clin Oncol. 15:1992;436-440.
-
(1992)
Am J Clin Oncol
, vol.15
, pp. 436-440
-
-
Feliu, J.1
Gonzalez-Bron, M.2
Berocal, A.3
-
19
-
-
0025127861
-
A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer
-
Bruera E., Macmilan K., Kuehn N. et al. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer. 66:1990;1279-1282.
-
(1990)
Cancer
, vol.66
, pp. 1279-1282
-
-
Bruera, E.1
MacMilan, K.2
Kuehn, N.3
-
20
-
-
0027442957
-
Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer
-
Kornblith A.B., Hollis D.R., Zuckerman E. et al. Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. J Clin Oncol. 11:1993;2081-2089.
-
(1993)
J Clin Oncol
, vol.11
, pp. 2081-2089
-
-
Kornblith, A.B.1
Hollis, D.R.2
Zuckerman, E.3
-
21
-
-
0027944745
-
Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia
-
Loprinzi C.L., Bernath A.M., Schaid D.J. et al. Phase III evaluation of 4 doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. Oncology. 51(Suppl 1):1994;2-7.
-
(1994)
Oncology
, vol.51
, Issue.SUPPL. 1
, pp. 2-7
-
-
Loprinzi, C.L.1
Bernath, A.M.2
Schaid, D.J.3
-
22
-
-
0028219815
-
Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy
-
Osoba D., Murray N., Gelmon K. et al. Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy. Oncology. 52:1994;43-49.
-
(1994)
Oncology
, vol.52
, pp. 43-49
-
-
Osoba, D.1
Murray, N.2
Gelmon, K.3
-
23
-
-
9044244145
-
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: A North Central Cancer Treatment Group study
-
Rowland K.M., Loprinzi C.L., Shaw E.G. et al. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol. 14:1996;135-141.
-
(1996)
J Clin Oncol
, vol.14
, pp. 135-141
-
-
Rowland, K.M.1
Loprinzi, C.L.2
Shaw, E.G.3
-
24
-
-
0028337478
-
Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma
-
Veenhof C.H., van der Burg M.E., Aalders N.M. et al. Phase II study of high-dose megestrol acetate in patients with advanced ovarian carcinoma. Eur J Cancer. 30A:1994;697-698.
-
(1994)
Eur J Cancer
, vol.30
, pp. 697-698
-
-
Veenhof, C.H.1
Van Der Burg, M.E.2
Aalders, N.M.3
-
25
-
-
0020025773
-
Occult cancer in patients with acute pulmonary embolism
-
Gore J., Appelbaum J.S., Green H.L. et al. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med. 96:1982;556-560.
-
(1982)
Ann Intern Med
, vol.96
, pp. 556-560
-
-
Gore, J.1
Appelbaum, J.S.2
Green, H.L.3
-
26
-
-
0021193823
-
Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients
-
Goodnough L.T., Saito H., Manni A. et al. Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients. Cancer. 54:1984;1264-1268.
-
(1984)
Cancer
, vol.54
, pp. 1264-1268
-
-
Goodnough, L.T.1
Saito, H.2
Manni, A.3
|